Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. News
May 8, 2025 - businesswire.com
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
Mar 26, 2025 - businesswire.com
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session
Feb 4, 2025 - businesswire.com
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations
Dec 16, 2024 - businesswire.com
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Cardio Diagnostics Holdings, Inc. Quantitative Score
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Cardio Diagnostics Holdings, Inc. Earnings & Revenue
Cardio Diagnostics Holdings, Inc. Financials
Table Compare
Compare CDIO metrics with: | |||
|---|---|---|---|
Earnings & Growth | CDIO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | CDIO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | CDIO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | CDIO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Cardio Diagnostics Holdings, Inc. Income
Cardio Diagnostics Holdings, Inc. Balance Sheet
Cardio Diagnostics Holdings, Inc. Cash Flow
Cardio Diagnostics Holdings, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Cardio Diagnostics Holdings, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Cardio Diagnostics Holdings, Inc. Executives
| Name | Role |
|---|---|
| Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, Chief Executive Officer & Director |
| Ms. Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Financial Officer & Principal Accounting Officer |
| Mr. Timur Dogan Ph.D. | Chief Technology Officer |
| Ms. Khullani Abdullahi J.D. | Vice President of Revenue & Strategy |
| Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, Chief Executive Officer & Director | 1989 | 311K | |
| Ms. Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Financial Officer & Principal Accounting Officer | Female | 1964 | 275K |
| Mr. Timur Dogan Ph.D. | Chief Technology Officer | Male | 1989 | 259.17K |
| Ms. Khullani Abdullahi J.D. | Vice President of Revenue & Strategy | Female | 1984 | -- |
| Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director | 1962 | -- |
Cardio Diagnostics Holdings, Inc. Insider Trades
| Date | 31 Mar |
| Name | Fung Peter K |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 18939 |
| Date | 31 Mar |
| Name | Betts Wendy J |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 18939 |
| Date | 31 Mar |
| Name | Burton Paul Frederick |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 18939 |
| Date | 31 Mar |
| Name | Intrater James |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 18939 |
| Date | 31 Dec |
| Name | Fung Peter K |
| Role | Director |
| Transaction | Disposed |
| Type | |
| Shares | 2272 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 31 Mar | Fung Peter K | Director | Acquired | A-Award | 18939 |
| 31 Mar | Betts Wendy J | Director | Acquired | A-Award | 18939 |
| 31 Mar | Burton Paul Frederick | Director | Acquired | A-Award | 18939 |
| 31 Mar | Intrater James | Director | Acquired | A-Award | 18939 |
| 31 Dec | Fung Peter K | Director | Disposed | 2272 |